Your browser doesn't support javascript.
loading
TALASUR trial: a single arm phase II trial assessing efficacy and safety of TALazoparib and Avelumab as maintenance therapy in platinum-Sensitive metastatic or locally advanced URothelial carcinoma.
Coquan, Elodie; Clarisse, Bénédicte; Lequesne, Justine; Brachet, Pierre-Emmanuel; Nevière, Zoé; Meriaux, Emeline; Bonnet, Isabelle; Castera, Marie; Goardon, Nicolas; Boutrois, Jeremy; Travers, Romain; Joly, Florence; Grellard, Jean-Michel; Thiery-Vuillemin, Antoine.
Afiliación
  • Coquan E; Medical Oncology Department, Centre François Baclesse, 3 Avenue du Général Harris, 14076, Caen Cedex 05, France. e.coquan@baclesse.unicancer.fr.
  • Clarisse B; Clinical Research Department Centre François Baclesse, 14076, Caen, France. e.coquan@baclesse.unicancer.fr.
  • Lequesne J; Clinical Research Department Centre François Baclesse, 14076, Caen, France.
  • Brachet PE; Clinical Research Department Centre François Baclesse, 14076, Caen, France.
  • Nevière Z; Medical Oncology Department, Centre François Baclesse, 3 Avenue du Général Harris, 14076, Caen Cedex 05, France.
  • Meriaux E; Clinical Research Department Centre François Baclesse, 14076, Caen, France.
  • Bonnet I; Medical Oncology Department, Centre François Baclesse, 3 Avenue du Général Harris, 14076, Caen Cedex 05, France.
  • Castera M; Medical Oncology Department, Centre François Baclesse, 3 Avenue du Général Harris, 14076, Caen Cedex 05, France.
  • Goardon N; Clinical Research Department Centre François Baclesse, 14076, Caen, France.
  • Boutrois J; Medical Oncology Department, Centre François Baclesse, 3 Avenue du Général Harris, 14076, Caen Cedex 05, France.
  • Travers R; Clinical Research Department Centre François Baclesse, 14076, Caen, France.
  • Joly F; Genetic and Oncology Biology Department, Centre François Baclesse, 14076, Caen, France.
  • Grellard JM; Clinical Research Department Centre François Baclesse, 14076, Caen, France.
  • Thiery-Vuillemin A; Northwest Data Center (CTD-CNO), Centre François Baclesse, 14076, Caen, France.
BMC Cancer ; 22(1): 1213, 2022 Nov 24.
Article en En | MEDLINE | ID: mdl-36434554
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias de la Vejiga Urinaria / Carcinoma de Células Transicionales / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials / Diagnostic_studies / Guideline Límite: Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Francia